Keywords: Biomarkers, Cancer, Hyperpolarized MRI, Immunotherapy, Melanoma, CEST, Esomeprazole
Motivation: Biomarkers to predict immunotherapy response are needed. AcidoCEST MRI and hyperpolarized magnetic resonance spectroscopy (HP-MRS) may predict response.
Goal(s):
Approach: AcidoCEST MRI and HP-MRS were used to measure extracellular pH (pHe) and lactate to pyruvate ratio. Imaging was performed on treated and untreated groups.
Results: Baseline lactate to pyruvate ratio and pHe were higher in the most resistant model compared to other models, but were unchanged in treatment vs control groups for the most resistant model.
Impact: Robust clinical tools are sorely needed to predict immunotherapy response. Development of a non-invasive clinical imaging tool would allow for less wasted time trying ineffective medications and more personalized treatment plans tailored so treatment is as effective as possible.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords